Advertisement

Topics

Phage Pharmaceuticals, Inc. Company Profile

19:14 EDT 19th March 2019 | BioPortfolio


News Articles [436 Associated News Articles listed on BioPortfolio]

Phage Therapy: Turning the Tables on Bacteria

CRISPR is a double-edged sword. It evolved to help bacteria slay phages. But CRISPR components can also be engineered into phages, arming them against bacteria. Consequently, phage therapy says, “En...

Phage therapy draws renewed interest to combat drug-resistant microbes

(Children's National Health System) In the face of growing antibiotic resistance and few antibiotics in the development pipeline, phages are drawing renewed research interest as a potential silver bul...

I gained a whole new understanding of the future of phage therapy working on this article about @LocusBio and @EligoBio. Many thanks to @timlu @CRISPRchef Luciano Marraffini, Charles Gersbach, @TheRiotMicrobe and more for their expertise. https://www.gene

I gained a whole new understanding of the future of phage therapy working on this article about @LocusBio and @EligoBio. Many thanks to @timlu @CRISPRchef Luciano Marraffini, Charles Gersbach, @T...

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

IONTAS Limited (IONTAS), a leader in the discovery and optimization of fully human antibodies, announced its Founder and Chief Executive Officer, John McCafferty was invited to attend the Nobel Prize ...

New peer-reviewed journal PHAGE: Therapy, Applications, and Research announced

(Mary Ann Liebert, Inc./Genetic Engineering News) Mary Ann Liebert Inc. publishers announces the launch of PHAGE: Therapy, Applications, and Research, the only peer-reviewed publication dedicated to t...

Lesaffre invests €15.5m in phage start-up

A chemical defence against phage infection

Adaptive Phage Therapeutics Enters into Collaboration Agreement with Researchers at Yale University to Manufacture and Supply Therapeutic Bacteriophage

Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pat...

Drugs and Medications [0 Results]

None

PubMed Articles [274 Associated PubMed Articles listed on BioPortfolio]

Crowd Controlled-Host Quorum Sensing Drives Phage Decision.

In the January issue of Cell, Silpe and Bassler (2019) characterize a phage that looks beyond the boundaries of infected host cells by directly wiretapping their intercellular communication. This info...

Host range and molecular characterization of a lytic Pradovirus-like Ralstonia phage RsoP1IDN isolated from Indonesia.

A lytic Ralstonia solanacearum-infecting phage designated Ralstonia phage RsoP1IDN was isolated from soil in Indonesia. The phage has a linear double-stranded DNA genome of 41,135 bp with 413-bp termi...

Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria.

Phage therapy, long overshadowed by chemical antibiotics, is garnering renewed interest in Western medicine. This stems from the rise in frequency of multi-drug-resistant bacterial infections in human...

Phage defense mechanisms and their genomic and phenotypic implications in the fish pathogen Vibrio anguillarum.

Vibrio anguillarum is a marine bacterium that can cause vibriosis in many fish and shellfish species. Although phage therapy has been proposed as an alternative treatment, the defense mechanisms again...

Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro.

Phage therapy is drawing more interest as antibiotic resistance becomes an ever more serious threat to public health. Bacterial biofilms represent a major obstacle in the fight against bacterial infec...

Clinical Trials [236 Associated Clinical Trials listed on BioPortfolio]

Evaluation and Detection of Facial Propionibacterium Acnes Bacteria and Phage

This multi-center, outpatient study will extract and evaluate the presence of facial P. acnes bacteria and phage strains using pore strips on up to 400 human subjects.

Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults

This study will examine the safety of ascending doses of AB-SA01 when topically applied to intact skin of healthy adults.

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Companies [1382 Associated Companies listed on BioPortfolio]

Phage Biotechnology Corp

Phage Biotechnology Corporation (Phage) is a Delaware Corporation, incorporated in 1998 and headquartered in Las Vegas, Nevada. The company has a manufacturing plant in Irvine, California, with resear...

Phage Pharmaceuticals, Inc.

Adaptive Phage Therapeutics (APT)

Adaptive Phage Therapeutics, Inc. (APT) is a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogeni...

Vincogen Corporation

Vincogen Corporation is a RF ID Biochip company established in year 2000 and has developed a proprietary radio-frequency (RF) biochip platform and T4 Phage Display platforms for use in several applica...

Special Phage Services

Few inventions in science and medicine have had such a profound effect on human health as the discovery and subsequent development of antibiotics. Following their introduction during World War II ma...

More Information about "Phage Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Phage Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Phage Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Phage Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phage Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Phage Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record